103 related articles for article (PubMed ID: 1718639)
1. The effect of FK506 and cyclosporin A on antigen-induced arthritis.
Blackham A; Griffiths RJ
Clin Exp Immunol; 1991 Nov; 86(2):224-8. PubMed ID: 1718639
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of FK506 and methotrexate on inflammatory cytokine levels in rat adjuvant-induced arthritis.
Magari K; Miyata S; Nishigaki F; Ohkubo Y; Mutoh S; Goto T
J Rheumatol; 2003 Oct; 30(10):2193-200. PubMed ID: 14528517
[TBL] [Abstract][Full Text] [Related]
3. Anti-arthritic properties of FK506 on collagen-induced arthritis in rats.
Magari K; Nishigaki F; Sasakawa T; Ogawa T; Miyata S; Ohkubo Y; Mutoh S; Goto T
Inflamm Res; 2003 Dec; 52(12):524-9. PubMed ID: 14991082
[TBL] [Abstract][Full Text] [Related]
4. FK506 is superior to methotrexate in therapeutic effects on advanced stage of rat adjuvant-induced arthritis.
Sakuma S; Nishigaki F; Magari K; Ogawa T; Miyata S; Ohkubo Y; Goto T
Inflamm Res; 2001 Oct; 50(10):509-14. PubMed ID: 11713905
[TBL] [Abstract][Full Text] [Related]
5. Calcineurin inhibitors exert rapid reduction of inflammatory pain in rat adjuvant-induced arthritis.
Magari K; Miyata S; Ohkubo Y; Mutoh S; Goto T
Br J Pharmacol; 2003 Jul; 139(5):927-34. PubMed ID: 12839866
[TBL] [Abstract][Full Text] [Related]
6. Effect of FTY720, a novel immunosuppressant, on adjuvant-induced arthritis in rats.
Matsuura M; Imayoshi T; Chiba K; Okumoto T
Inflamm Res; 2000 Aug; 49(8):404-10. PubMed ID: 11028757
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory cytokine levels in paw tissues during development of rat collagen-induced arthritis: effect of FK506, an inhibitor of T cell activation.
Magari K; Miyata S; Ohkubo Y; Mutoh S
Inflamm Res; 2004 Sep; 53(9):469-74. PubMed ID: 15551000
[TBL] [Abstract][Full Text] [Related]
8. Effect of FK506 on the development of diabetes in BB rats in comparison with that of cyclosporin.
Wakugami T; Islam MR; Higa S; Murakami K; Mimura G
Tohoku J Exp Med; 1993 Jan; 169(1):21-9. PubMed ID: 7692621
[TBL] [Abstract][Full Text] [Related]
9. FK506 ameliorates spontaneous locomotor activity in collagen-induced arthritis: implication of distinct effect from suppression of inflammation.
Sasakawa T; Sasakawa Y; Ohkubo Y; Mutoh S
Int Immunopharmacol; 2005 Mar; 5(3):503-10. PubMed ID: 15683847
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of cyclophosphamide, cyclosporin A and FK506 against antigen-induced lung eosinophilia in guinea-pigs.
Norris AA; Jackson DM; Eady RP
Clin Exp Immunol; 1992 Sep; 89(3):347-50. PubMed ID: 1381297
[TBL] [Abstract][Full Text] [Related]
11. Novel hyaluronic acid-methotrexate conjugate suppresses joint inflammation in the rat knee: efficacy and safety evaluation in two rat arthritis models.
Tamura T; Higuchi Y; Kitamura H; Murao N; Saitoh R; Morikawa T; Sato H
Arthritis Res Ther; 2016 Apr; 18():79. PubMed ID: 27039182
[TBL] [Abstract][Full Text] [Related]
12. Enzyme and combination therapy with cyclosporin A in the rat developing adjuvant arthritis.
Rovenská E; Svík K; Stancíková M; Rovenský J
Int J Tissue React; 1999; 21(4):105-11. PubMed ID: 10761540
[TBL] [Abstract][Full Text] [Related]
13. Effects of a new immunosuppressive agent, FK506, on experimental autoimmune uveoretinitis in rats.
Kawashima H; Fujino Y; Mochizuki M
Invest Ophthalmol Vis Sci; 1988 Aug; 29(8):1265-71. PubMed ID: 2458329
[TBL] [Abstract][Full Text] [Related]
14. FK506 attenuates developing and established joint inflammation and suppresses interleukin 6 and nitric oxide expression in bacterial cell wall induced polyarthritis.
Fuseler JW; Hearth-Holmes M; Grisham MB; Kang D; Laroux FS; Wolf RE
J Rheumatol; 2000 Jan; 27(1):190-9. PubMed ID: 10648038
[TBL] [Abstract][Full Text] [Related]
15. [Immunotherapy in ocular diseases].
Mochizuki M
Nippon Ganka Gakkai Zasshi; 1992 Dec; 96(12):1608-34. PubMed ID: 1283052
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporin A prevents the histologic damage of antigen arthritis without inducing fibrosis.
Benito MJ; Sánchez-Pernaute O; López-Armada MJ; Hernández P; Palacios I; Egido J; Herrero-Beaumont G
Arthritis Rheum; 2000 Feb; 43(2):311-9. PubMed ID: 10693870
[TBL] [Abstract][Full Text] [Related]
17. Detection of synovial macrophages in an experimental rabbit model of antigen-induced arthritis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging.
Lutz AM; Seemayer C; Corot C; Gay RE; Goepfert K; Michel BA; Marincek B; Gay S; Weishaupt D
Radiology; 2004 Oct; 233(1):149-57. PubMed ID: 15333767
[TBL] [Abstract][Full Text] [Related]
18. Sirolimus (rapamycin, Rapamune) and combination therapy with cyclosporin A in the rat developing adjuvant arthritis model: correlation with blood levels and the effects of different oral formulations.
Carlson RP; Hartman DA; Ochalski SJ; Zimmerman JL; Glaser KB
Inflamm Res; 1998 Aug; 47(8):339-44. PubMed ID: 9754868
[TBL] [Abstract][Full Text] [Related]
19. The combination of FK506 and an anti-CD147 mAb exerts potential therapeutic effects on a mouse model of collagen-induced arthritis.
Luan J; Zhang K; Yang P; Zhang Y; Feng F; Zhu YM; Zhu P; Chen ZN
Mol Immunol; 2018 Sep; 101():1-9. PubMed ID: 29852454
[TBL] [Abstract][Full Text] [Related]
20. Effect of dose of cyclosporine or FK506 and antithrombotic agents on cardiac allograft vascular disease in heterotopically transplanted hearts in rats.
Hisatomi K; Isomura T; Ohashi M; Tamehiro K; Sato T; Tayama E; Ohishi K; Kohjiro M
J Heart Lung Transplant; 1995; 14(1 Pt 1):113-8. PubMed ID: 7537098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
